RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tenax Therapeutics Stock

Tenax Therapeutics ROA 2024

Tenax Therapeutics ROA

-0.66

Ticker

TENX

ISIN

US88032L2097

WKN

A2JEYS

In 2024, Tenax Therapeutics's return on assets (ROA) was -0.66, a -79.66% increase from the -3.24 ROA in the previous year.

Tenax Therapeutics Aktienanalyse

What does Tenax Therapeutics do?

Tenax Therapeutics Inc. is a biopharmaceutical company based in Morrisville, North Carolina. It specializes in the development of therapeutics for cardiovascular and pulmonary diseases. The company was founded in 1967 by a group of physicians and scientists. Formerly known as Oxygen Biotherapeutics, it was rebranded as Tenax Therapeutics in 2014. Tenax Therapeutics' business model is focused on the development, manufacturing, and marketing of products for rare diseases. The company aims to develop innovative therapies for severe and life-threatening diseases where there is a high demand for novel treatment options. The focus of Tenax Therapeutics is on cardiovascular and respiratory diseases. The company specializes in the development of medications for the treatment of severe or life-threatening conditions such as cardiogenic shock, pulmonary hypertension, and pulmonary embolism. Over the years, Tenax Therapeutics has established several divisions to streamline its research and development activities. One of the key divisions is clinical research, where the company conducts clinical trials to test the efficacy and safety of its products and obtain regulatory approval. Another pillar of the company is product development, where Tenax Therapeutics develops new compounds and medications to specifically target conditions like cardiogenic shock. Given the high demand for new therapies for rare diseases, the company adopts a highly focused approach and concentrates on developing products for specific indications. Tenax Therapeutics' extensive product portfolio includes various medications and therapeutics that can be used to treat cardiovascular and pulmonary diseases. One important representative in this area is Levosimendan, a vasodilator and inotropic medication used in patients with cardiogenic shock, as well as heart failure and other cardiovascular conditions. Another product in Tenax Therapeutics' portfolio is the active substance ANX-188. This medication is used for the treatment of patients with severe cardiogenic shock and has already been tested in clinical trials. Overall, Tenax Therapeutics aims to develop innovative and effective therapies for rare diseases of the cardiovascular and pulmonary systems. The company strives to address the medical need in this field and ensure high patient satisfaction. Tenax Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Tenax Therapeutics's Return on Assets (ROA)

Tenax Therapeutics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Tenax Therapeutics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Tenax Therapeutics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Tenax Therapeutics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Tenax Therapeutics stock

What is the Return on Assets (ROA) of Tenax Therapeutics this year?

The Return on Assets (ROA) of Tenax Therapeutics is -0.66 undefined this year.

What was the ROA of Tenax Therapeutics compared to the previous year?

The ROA of Tenax Therapeutics has increased by -79.66% compared to the previous year.

What consequences do high ROA have for investors of Tenax Therapeutics?

A high ROA is advantageous for investors of Tenax Therapeutics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Tenax Therapeutics?

A low ROA can be unfavorable for investors of Tenax Therapeutics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Tenax Therapeutics affect the company?

An increase in ROA of Tenax Therapeutics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Tenax Therapeutics impact the company?

A reduction in the ROA of Tenax Therapeutics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Tenax Therapeutics?

Some factors that can influence the ROA of Tenax Therapeutics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Tenax Therapeutics important for investors?

The ROA of Tenax Therapeutics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Tenax Therapeutics take to improve ROA?

To improve ROA, Tenax Therapeutics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Tenax Therapeutics pay?

Over the past 12 months, Tenax Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tenax Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Tenax Therapeutics?

The current dividend yield of Tenax Therapeutics is .

When does Tenax Therapeutics pay dividends?

Tenax Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tenax Therapeutics?

Tenax Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Tenax Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tenax Therapeutics located?

Tenax Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tenax Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tenax Therapeutics from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Tenax Therapeutics pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Tenax Therapeutics in the year 2023?

In the year 2023, Tenax Therapeutics distributed 0 USD as dividends.

In which currency does Tenax Therapeutics pay out the dividend?

The dividends of Tenax Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Tenax Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Tenax Therapeutics

Our stock analysis for Tenax Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tenax Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.